Sílvia Saumell - Concepedia

Author

Sílvia Saumell

Municipal Institute for Medical Research ORCID

Also Known As

S. Saumell, Silvia Saumell, Silvia Saumell Tutusaus, Sílvia Saumell, Sílvia Saumell Tutusaus

Publications

274

Citations

H-Index

Concepts

All Affiliations

Municipal Institute for Medical Research Hospital Del Mar Universitat Autònoma de Barcelona Hospital Universitario Central de Asturias Vall d'Hebron Hospital Universitari

About

Sílvia Saumell is an author at Municipal Institute for Medical Research specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	164
2	Immunology	2	2	73
3	Health Sciences	1	1	24
4	Public Health	1	1	56
5	Epidemiology	1	1	56

Sílvia Saumell

Publications

237

Citations

H-Index

Page 1

	Year	Citations
Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients Alberto Álvarez‐Larrán, Beatríz Bellosillo, Luz Martínez‐Avilés, British Journal of Haematology Hematological MalignancyTranslational MedicineBone Marrow FailureLaboratory HematologyPolycythaemia Vera	2009	56
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes Julia Montoro, Laura Gallur, Brayan Merchán, Annals of Hematology Autoimmune DisordersRheumatologyMyelodysplastic Syndrome PatientsHematological MalignancyBone Marrow Failure	2018	49
Single nucleotide polymorphism array karyotyping: A diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing Leonor Arenillas, Mar Mallo, Fernando Ramos, Genes Chromosomes and Cancer	2013	43
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes Sílvia Saumell, Lourdes Florensa, Elisa Luño, British Journal of Haematology	2012	30
Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not? Sílvia Saumell, Françesc Solé, Leonor Arenillas, PLoS ONE CytogeneticsMixed-phenotype Acute LeukemiaGeneticsImmunologyPathology	2015	24
Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma Eva Gimeno, Blanca Sánchez‐González, Alberto Álvarez‐Larrán, Leukemia Research Intermediate DoseLymphoid NeoplasiaOncologyMedicineFrail Elderly Patients	2010	21
Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin David Conde‐Estévez, Sílvia Saumell, Antonio Salar, Anti-Cancer Drugs Concentrated DoxorubicinOncologyMedicineHematologySevere Extravasation	2010	14

Page 1